The European Union has reclassified medicinal marijuana as a lower-risk drug. This reclassification will facilitate research into the safety and efficacy of marijuana for treating cancer and severe mental health disorders.

La reclasificación permitirán realizar investigaciones sobre la seguridad y eficacia de la marihuana para tratamientos alternativos para cáncer y trastornos serios de salud mental